INS and Parkinson disease: Metabolic dysfunction (T2DM, hyperinsulinemia, obesity) is a risk factor for neurodegeneration, especially in AD and PD, reflecting shared pathways including oxidative stress, chronic inflammation, mitochondrial dysfunction, and impaired insulin signaling - hence sometimes termed “Type 3 diabetes” in AD [9].